Sector: Pharmaceuticals & Biotechnology

Large Cap

Anthem Biosciences Share Price

ANTHEM

₹754.95

2.95(0.39%)

10th Jul 2026 | 3:28 PM

NSE : ANTHEM

Open Free Demat Account

Anthem Biosciences Performance

Price Movement

₹754.95

₹749.00

₹759.50

↘ Today's Low↗ Today's High

1 Year Performance

₹754.95

₹579.15

₹873.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹759.50

Low₹749.00

Open at₹753.20

Prev Close₹752.00

Volumes3.35 L

Avg Price₹755.07

Lower Circuit₹601.60

Upper Circuit₹902.40

Historical Performance

3M High₹825.65

3M Low₹709.50

1 Yr High₹873.50

1 Yr Low₹579.15

3 Yr High₹873.50

3 Yr Low₹579.15

5 Yr High₹873.50

5 Yr Low₹579.15

Summary

As of 10-07-2026 20:25, Anthem Biosciences Ltd. share price today is ₹0, with a change of ₹-752.00 (-100.00%) from the previous close of ₹752. The stock opened at ₹753.2 and traded between ₹749 and ₹759.5, with a total traded volume of 334847 shares. The company has a market capitalization of ₹42352.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹873.5 and ₹579.15, respectively.

Anthem Biosciences Ltd. valuation metrics include a P/E ratio of 71.6, EPS of ₹10.55, and book value of ₹13.90. Profitability indicators show ROE of 19.45% along with a dividend yield of 0.3%. Anthem Biosciences Ltd. has reported revenue of ₹2124.33 Cr and net profit of ₹591.79 Cr.

Anthem Biosciences Ltd. technical indicators include Day RSI at 43.57, Day MFI at 33.55, Day ADX at 10.64. Additional indicators include Commodity Channel Index (CCI) at -160.4 and Williams %R at -86.86. Momentum indicators show Day MACD at -2.25, Day MACD Signal Line at 0.58, DayATR at 21.39. Rate of Change indicators for Anthem Biosciences Ltd. include ROC125 at 14.91 and ROC21 at -3.37.

Exponential moving averages include EMA5 at ₹759.2, EMA10 at ₹764, EMA12 at ₹765.1, EMA20 at ₹767.3, EMA26 at ₹767.4, EMA50 at ₹759.6, EMA100 at ₹741.1, EMA200 at ₹731.4. Simple moving averages include SMA5 at ₹762.4, SMA10 at ₹765.5, SMA20 at ₹771.7, SMA30 at ₹767.9, SMA50 at ₹772.8, SMA100 at ₹729.5, SMA150 at ₹699.8, SMA200 at ₹708.9.

Support levels for Anthem Biosciences are placed at First Support ₹744.75, Second Support ₹737.50, Third Support ₹725.90. Resistance levels are seen at First Resistance ₹763.60, Second Resistance ₹775.20, Third Resistance ₹782.45. Anthem Biosciences Ltd. shareholding pattern shows promoter holding at 74.68%, FII holding at 1.28%, DII holding at 0%, public holding at 12.48%.

Anthem Biosciences Fundamentals

Market Cap

High in industry

42,352.30 Cr.

PE Ratio (TTM)

High in industry

71.60

Dividend Yield

Below industry Median

0.30

Net Profit TTM

31.1% incr over last year

591.79

Net Profit Growth

31.1% incr over last year

591.79

PEG Ratio

High in industry

2.30

ROE

3.9% incr over last year

19.45

Operating Revenue TTM

2,124.33

Operating Revenue Growth

15.2% incr over last year

Book Value

High in industry

13.90

MFI

MFI is mid-range

33.55

RSI

RSI is mid-range

43.57

EPS (TTM)

10.55

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

36.57

Operating Profit Qtr.

267.22

Net Profit Qtr.

189.76

Operating Revenue Qtr.

610.94

PB Ratio

13.90

Anthem Biosciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	582.50	416.58	552.23	538.01	478.98
Operating Expense	315.51	253.53	326.57	342.58	280.87
Operating Profit	266.99	163.05	225.66	195.43	198.11
Depreciation	26.28	26.75	23.92	22.61	20.99
Interest	1.58	1.13	2.23	1.61	2.10
Tax	89.06	37.98	54.87	50.60	90.28
Net Profit	211.66	112.12	198.43	148.34	122.56

Anthem Biosciences Technicals

Anthem Biosciences Ltd. EMA & SMA

₹754.95

6.50 (0.87%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹759.2

Day EMA10 ₹764

Day EMA12 ₹765.1

Day EMA20 ₹767.3

Day EMA26 ₹767.4

Day EMA50 ₹759.6

Day EMA100 ₹741.1

Day EMA200 ₹731.4

Anthem Biosciences Support and Resistance

Resistance

First Resistance₹763.60

Second Resistance₹775.20

Third Resistance₹782.45

Support

First Support₹744.75

Second Support₹737.50

Third Support₹725.90

Technical Indicators

Day RSI43.57

Day MFI33.55

Day ADX10.64

Day Commodity Channel Index-160.40

William-86.86

Day MACD-2.25

Day MACD Signal Line0.58

Day ATR21.39

Day ROC12514.91

Day ROC21-3.37

Anthem Biosciences Shareholding Pattern

Held By	Sep 2025	Dec 2025	Mar 2026
Promoter	74.7	74.7	74.7
FII	1.7	1.4	1.3
DII	7.2	7.6	11.5
Public	16.4	16.3	12.5

Anthem Biosciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.08 L	4.1 L	50.67%
Week	3.11 L	5.35 L	58.20%
1 Month	3.26 L	6.16 L	52.96%
6 Month	4.33 L	6.27 L	69.12%

Anthem Biosciences SWOT Analysis

Strengths18

Weakness7

Opportunity3

Threats1

Benjamin Graham Value Screen

Stocks in Buy Zone with High Momentum Score Last Month

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with high TTM EPS Growth

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Negative to Positive growth in Sales and Profit with Strong Price momentum

Top Gainers

Anthem Biosciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
25 Jun, 2026	2	FINAL	26 Jun, 2026	Equity Share

Anthem Biosciences Stock Comparison

Financials	Rubicon Research Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	75.10	37.10	54.70	-70.30
1 Year Return	190.14	57.98	43.82	0.21	-14.62
ROCE	24.32	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on ANTHEM

What are the PE and PB ratios for Anthem Biosciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Anthem Biosciences Ltd. is 71.6, and the Price-to-Book (PB) ratio is 13.9.

What is the 52-Week High and Low for Anthem Biosciences Ltd.?

Over the past 52 weeks, the highest price reached by Anthem Biosciences Ltd. shares was ₹ 873.5, and the lowest price was ₹ 579.15.

Who are the major shareholders of Anthem Biosciences Ltd.?

Significant shareholdings in Anthem Biosciences Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Anthem Biosciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Anthem Biosciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Anthem Biosciences Ltd.?

Anthem Biosciences Ltd. last declared a FINAL dividend of ₹ 2 per share for the financial period ending 2026. The record date was set as 2026-06-25, and the payment was/is scheduled around 2026-06-25. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy